Borderline or locally advanced pancreatic adenocarcinoma: A single center experience on the FOLFIRINOX induction regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Borderline or locally advanced pancreatic adenocarcinoma: A single center experience on the FOLFIRINOX induction regimen

Published:2020-08 Issue:8 Volume:46 Page:1510-1515
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Garnier Jonathan,Ewald Jacques,Marchese Ugo,Gilabert Marine,Moureau-Zabotto Laurence,Giovannini Marc,Poizat Flora,Delpero Jean-Robert,Turrini Olivier

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference35 articles.

1. Cancer statistics;Siegel;CA A Cancer J Clin,2017

2. Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: shifting the survival curve for patients with locally advanced pancreatic cancer;Epelboym;World J Surg,2014

3. Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology;Tempero;J Natl Compr Canc Netw,2017

4. Advanced pancreatic carcinoma: current treatment and future challenges;Stathis;Nat Rev Clin Oncol,2010

5. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience;Faris;Oncol,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy: A Single-Center Experience;Annals of Surgical Oncology;2024-07-02

2. Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy;Annals of Surgical Oncology;2023-12-17

3. Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy;HPB;2023-09

4. Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer;2022-12-30

5. Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer;Journal of the National Comprehensive Cancer Network;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3